// App-Quantinova.ai

P2-01-08 : Different Numbers and Prognostic Significance of Circulating Tumour Cells in Patients with Metastatic Breast Cancer According to Immunohistochemical Subtypes.

Researchers

Presenter

  • Peeters DJ

Principal Investigators

  • van Dam P-J

  • Wuyts H

  • van Dam PA

  • Vermeulen PB

  • Dirix LY

  • Van den Eynden GG

  • Jeuris K

  • Prove A

  • Rutten A

  • Peeters M

  • Pauwels P

  • Van Laere SJ

  • Hauspy J

Medical Centers

  • Catholic University of Leuven, Leuven, Vlaams-Brabant, Belgium

  • GZA Hospital Sint-Augustinus, Antwerp, Belgium.

  • University of Antwerp, Wilrijk, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved